These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28419727)

  • 1. Endotoxin testing of a wound debridement device containing medicinal Lucilia sericata larvae.
    Pickles SF; Pritchard DI
    Wound Repair Regen; 2017 May; 25(3):498-501. PubMed ID: 28419727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality control of a medicinal larval (Lucilia sericata) debridement device based on released gelatinase activity.
    Pickles SF; Pritchard DI
    Med Vet Entomol; 2017 Jun; 31(2):200-206. PubMed ID: 28117913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor.
    Linger RJ; Belikoff EJ; Yan Y; Li F; Wantuch HA; Fitzsimons HL; Scott MJ
    BMC Biotechnol; 2016 Mar; 16():30. PubMed ID: 27006073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impacts of larval density and protease inhibition on feeding in medicinal larvae of the greenbottle fly Lucilia sericata.
    Wilson MR; Nigam Y; Jung W; Knight J; Pritchard DI
    Med Vet Entomol; 2016 Mar; 30(1):1-7. PubMed ID: 26463514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the optimal treatment time for larval therapy? A study on incubation time and tissue debridement by bagged maggots of the greenbottle fly, Lucilia sericata.
    Wilson MR; Nigam Y; Knight J; Pritchard DI
    Int Wound J; 2019 Feb; 16(1):219-225. PubMed ID: 30379404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Lucilia sericata larval excretion/secretion (ES) products on cellular responses in wound healing.
    Gazi U; Taylan-Ozkan A; Mumcuoglu KY
    Med Vet Entomol; 2021 Sep; 35(3):257-266. PubMed ID: 33314340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rearing larvae of Lucilia sericata for chronic ulcer treatment--an improved method.
    Wolff H; Hansson C
    Acta Derm Venereol; 2005; 85(2):126-31. PubMed ID: 15823905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defensins of
    Bazaliński D; Przybek-Mita J; Lisowicz K; Skórka M; Więch P
    Int J Environ Res Public Health; 2023 Mar; 20(7):. PubMed ID: 37047972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and survival of blowfly Lucilia sericata larvae under simulated wound conditions: implications for maggot debridement therapy.
    Čičková H; Kozánek M; Takáč P
    Med Vet Entomol; 2015 Dec; 29(4):416-24. PubMed ID: 26382290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds.
    Chambers L; Woodrow S; Brown AP; Harris PD; Phillips D; Hall M; Church JC; Pritchard DI
    Br J Dermatol; 2003 Jan; 148(1):14-23. PubMed ID: 12534589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Jonah-like chymotrypsin from the therapeutic maggot Lucilia sericata plays a role in wound debridement and coagulation.
    Pöppel AK; Kahl M; Baumann A; Wiesner J; Gökçen A; Beckert A; Preissner KT; Vilcinskas A; Franta Z
    Insect Biochem Mol Biol; 2016 Mar; 70():138-47. PubMed ID: 26773746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple actions of Lucilia sericata larvae in hard-to-heal wounds: larval secretions contain molecules that accelerate wound healing, reduce chronic inflammation and inhibit bacterial infection.
    Cazander G; Pritchard DI; Nigam Y; Jung W; Nibbering PH
    Bioessays; 2013 Dec; 35(12):1083-92. PubMed ID: 24123092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midgut lysozymes of Lucilia sericata - new antimicrobials involved in maggot debridement therapy.
    Valachova I; Takac P; Majtan J
    Insect Mol Biol; 2014 Dec; 23(6):779-87. PubMed ID: 25098233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maggot excretion products from the blowfly Lucilia sericata contain contact phase/intrinsic pathway-like proteases with procoagulant functions.
    Kahl M; Gökçen A; Fischer S; Bäumer M; Wiesner J; Lochnit G; Wygrecka M; Vilcinskas A; Preissner KT
    Thromb Haemost; 2015 Aug; 114(2):277-88. PubMed ID: 25948398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of broad-spectrum antiseptics in production of disinfected maggots of Lucilia sericata for use in wound debridement therapy.
    Taleb M
    Wound Repair Regen; 2021 Nov; 29(6):1017-1023. PubMed ID: 34633134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of Lucilia sericata larvae extraction/secretion-treated skin wounds.
    Polat E; Aksöz İ; Arkan H; Coşkunpınar E; Akbaş F; Onaran İ
    Gene; 2014 Oct; 550(2):223-9. PubMed ID: 25153915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excretions/secretions from medicinal larvae (Lucilia sericata) inhibit complement activation by two mechanisms.
    Tamura T; Cazander G; Rooijakkers SH; Trouw LA; Nibbering PH
    Wound Repair Regen; 2017 Jan; 25(1):41-50. PubMed ID: 28019718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIME management by medicinal larvae.
    Pritchard DI; Čeřovský V; Nigam Y; Pickles SF; Cazander G; Nibbering PH; Bültemann A; Jung W
    Int Wound J; 2016 Aug; 13(4):475-84. PubMed ID: 26179750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wound debridement potential of glycosidases of the wound-healing maggot, Lucilia sericata.
    Telford G; Brown AP; Rich A; English JS; Pritchard DI
    Med Vet Entomol; 2012 Sep; 26(3):291-9. PubMed ID: 22620282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biosurgical débridement using Lucilia sericata-maggots - an update].
    Nenoff P; Herrmann A; Gerlach C; Herrmann J; Simon JC
    Wien Med Wochenschr; 2010 Dec; 160(21-22):578-85. PubMed ID: 20714816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.